1. Home
  2. SRDX vs PNNT Comparison

SRDX vs PNNT Comparison

Compare SRDX & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • PNNT
  • Stock Information
  • Founded
  • SRDX 1979
  • PNNT 2007
  • Country
  • SRDX United States
  • PNNT United States
  • Employees
  • SRDX N/A
  • PNNT N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • PNNT Finance: Consumer Services
  • Sector
  • SRDX Health Care
  • PNNT Finance
  • Exchange
  • SRDX Nasdaq
  • PNNT Nasdaq
  • Market Cap
  • SRDX 457.0M
  • PNNT 472.7M
  • IPO Year
  • SRDX 1998
  • PNNT 2007
  • Fundamental
  • Price
  • SRDX $32.03
  • PNNT $6.87
  • Analyst Decision
  • SRDX Buy
  • PNNT Sell
  • Analyst Count
  • SRDX 3
  • PNNT 4
  • Target Price
  • SRDX $43.00
  • PNNT $6.33
  • AVG Volume (30 Days)
  • SRDX 244.1K
  • PNNT 460.4K
  • Earning Date
  • SRDX 11-05-2025
  • PNNT 08-11-2025
  • Dividend Yield
  • SRDX N/A
  • PNNT 13.95%
  • EPS Growth
  • SRDX N/A
  • PNNT 21.65
  • EPS
  • SRDX N/A
  • PNNT 0.80
  • Revenue
  • SRDX $120,801,000.00
  • PNNT $130,923,000.00
  • Revenue This Year
  • SRDX N/A
  • PNNT N/A
  • Revenue Next Year
  • SRDX $3.38
  • PNNT N/A
  • P/E Ratio
  • SRDX N/A
  • PNNT $8.63
  • Revenue Growth
  • SRDX N/A
  • PNNT N/A
  • 52 Week Low
  • SRDX $26.00
  • PNNT $5.72
  • 52 Week High
  • SRDX $40.39
  • PNNT $7.53
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 52.07
  • PNNT 52.54
  • Support Level
  • SRDX $31.34
  • PNNT $7.11
  • Resistance Level
  • SRDX $33.17
  • PNNT $7.29
  • Average True Range (ATR)
  • SRDX 0.70
  • PNNT 0.07
  • MACD
  • SRDX -1.98
  • PNNT -0.41
  • Stochastic Oscillator
  • SRDX 92.20
  • PNNT 94.24

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: